Only 1 in 4 residential treatment centers for teens offers a recommended medicine for opioid addiction, according to a study that exposes an important gap in care.
Posing as an aunt or uncle seeking help for a fictitious 16-year-old who survived a fentanyl overdose, researchers called U.S. rehabs and asked if they offered the treatment medication buprenorphine.
Of 160 facilities with care for teens, just 39 provided buprenorphine, also known by the brand name Suboxone. One hundred said they didn’t and 21 said they didn’t know.
Read this story now for free
To continue reading, sign up for our newsletter and get unlimited access to WABE.org
You can select your preferences for news and local content. We will never share your email address. Learn how your newsletter sign-up will support WABE and Public Media
